Johnson & Johnson to pay $2.2B in U.S. health care fraud settlement

CBS News - Health care giant Johnson & Johnson and its subsidiaries have agreed to pay over $2.2 billion to resolve criminal and civil allegations of promoting three prescription drugs for off-label uses not approved by the Food and Drug Administration, the Department of Justice announced on Monday.  Read more.